Dr. Niall Thomas Prendergast, MD

Dr. Prendergast practices at UPMC East in Monroeville, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Prendergast's NPI, 1225442890, was assigned on June 11, 2014. Dr. Prendergast graduated from Washington University School of Medicine in 2014. Dr. Prendergast holds Pennsylvania license MD474835.

Dr. Prendergast's primary practice is UPMC East, at 2775 Mosside Boulevard, Monroeville, PA 15146 in Allegheny County. The practice phone is (412) 357-3000.

Dr. Prendergast's primary practice is UPMC East in Monroeville, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Prendergast is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Prendergast to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prendergast practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Prendergast's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Prendergast's licenses on file in 2 states: Pennsylvania and Missouri.

CMS data shows 78 Medicare services from Dr. Prendergast across 2 procedure codes in 2024, for 34 Medicare patients. Medicare paid $9,241 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Prendergast in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prendergast's median patient age at 74, with 38% women.

In 2017, Dr. Prendergast wrote 553 Medicare Part D claims. They cover 24 drugs, with $25,683 in total drug cost. In 2016, CMS named 660 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Prendergast for performance year 2024, reported as part of a group. Dr. Prendergast accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Prendergast from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Ceribell, Inc. paid the most, $318.

Dr. Prendergast graduated from Washington University School of Medicine in 2014.